Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
38.04
+1.05 (2.84%)
At close: Jun 26, 2026, 4:00 PM EDT
37.99
-0.05 (-0.13%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Viking Therapeutics Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Viking Therapeutics stock have an average target of 92.15, with a low estimate of 70 and a high estimate of 125. The average target predicts an increase of 142.25% from the current stock price of 38.04.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Viking Therapeutics stock from 20 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 13 | 13 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 19 | 19 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Buy Reiterates $85 | Buy | Reiterates | $85 | +123.45% | Jun 25, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $95 | Buy | Maintains | $95 | +149.74% | Jun 25, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $70 | Buy | Reiterates | $70 | +84.02% | Jun 25, 2026 |
| Raymond James | Raymond James | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 24, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $102 | Buy | Reiterates | $102 | +168.14% | Jun 24, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.72
from -3.19
EPS Next Year
-4.57
from -4.72
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.81 | -2.22 | |
| Avg | -4.72 | -4.57 | |
| Low | -5.72 | -6.41 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.